Imuldosa 130 mg / 26 ml

Imuldosa 130 mg / 26 ml is a medicine authorised by Swissmedic under authorisation number 70225. The authorisation holder is Accord Healthcare AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 November 2025 and the authorisation is limited until 13 November 2030. ATC code L04AC05 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 70225
  • ATC L04AC05
  • Biotechnological medicines
Authorisation data
Authorisation number70225
NameImuldosa 130 mg / 26 ml
Full nameImuldosa 130 mg / 26 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderAccord Healthcare AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AC05
First authorisation14 November 2025
Authorisation validity13 November 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Imuldosa 130 mg / 26 ml, Konzentrat zur Herstellung einer InfusionslösungB21 November 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L04AC0507.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Imuldosa 130 mg / 26 ml authorised in Switzerland?

Yes. Imuldosa 130 mg / 26 ml is authorised by Swissmedic under authorisation number 70225, data as of 01 September 2026. The authorisation is limited until 13 November 2030.

Which dispensing category does Imuldosa 130 mg / 26 ml have?

Imuldosa 130 mg / 26 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Imuldosa 130 mg / 26 ml?

The authorisation holder is Accord Healthcare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com